Yes, migraines can cause facial pain, and the mechanism is well mapped: the trigeminal nerve that supplies sensation to the forehead, eye, cheek, and jaw is the same nerve whose activation drives migraine headache. In studies of migraine sufferers, roughly 40 to 60 percent report pain or allodynia (pain from light touch) in facial territory during an attack. The pain is usually one-sided and tracks the first (ophthalmic) or second (maxillary) trigeminal branch, around the eye and upper cheek. Facial pain that is severe, isolated, or comes with fever, vision loss, or weakness is not migraine and needs urgent evaluation.
The Trigeminal Mechanism: Why Head Pain Reaches the Face
Migraine is not a blood vessel problem that spreads outward. It is a brainstem and trigeminovascular event, and the face sits inside that circuit. The trigeminal nerve has three divisions: V1 (forehead, eye, scalp), V2 (cheek, upper jaw, midface), and V3 (lower jaw, chin, temple). Migraine activation begins in the trigeminocervical complex, a relay in the brainstem that receives input from all three divisions plus the upper neck.
When that relay is sensitized, the brain misreads ordinary signals from facial skin as pain. This is central sensitization, and it is the reason a migraineur can find a gentle touch on the cheek unbearable during an attack. The threshold drops, not the nerve damage.
A second mechanism explains why so many facial-pain patients get misdiagnosed. The sphenopalatine ganglion, a cluster of nerve cells behind the nose, sits on V2 territory and can fire during migraine, producing pain that feels sinus-like: pressure behind the cheek, aching upper teeth, and nasal congestion. In plain terms: the face hurts because the same nerve switchboard that runs the headache also runs the face.
Quantitatively, the trigeminal nerve carries roughly 100,000 to 150,000 sensory fibers per division, and sensitization can lower mechanical pain thresholds in facial skin by 30 to 50 percent during an attack. That drop is measurable with von Frey filament testing and is one of the clearest objective signs that facial pain in migraine is real, not psychological.
How Common Is Facial Pain in Migraine? The Numbers
Facial involvement is common but undercounted because most headache questionnaires ask only about head pain. When researchers specifically probe the face, the prevalence jumps.
| Measure | Reported figure | Source context |
|---|---|---|
| Migraineurs with any facial pain during attacks | 40–60% | Clinic-based series, trigeminal distribution studies |
| Migraineurs with facial allodynia (touch hurts) | 20–35% | Quantitative sensory testing cohorts |
| Pain localized to V1 (eye/forehead) | ~50% of facial cases | Distribution mapping |
| Pain localized to V2 (cheek/upper jaw) | ~30% | Distribution mapping |
| Pain localized to V3 (jaw/chin) | ~10–15% | Distribution mapping |
| Facial pain as the sole or dominant complaint | 5–10% | "Facial migraine" case series |
| Misdiagnosed as sinus headache initially | Up to 40% | Sinus versus migraine comparison studies |
The sinus misdiagnosis figure matters. In one comparison of patients carrying a sinus-headache diagnosis, roughly 80 to 90 percent met criteria for migraine when formally assessed. Many had been treated with antibiotics for years without relief.
The Time Course: When Facial Pain Appears in an Attack
Facial pain follows the migraine phase structure, and its timing is a diagnostic clue. Pain that peaks before the headache or lingers after it suggests a different process.
| Phase | Typical timing | What happens to the face |
|---|---|---|
| Prodrome | 2–48 hours before headache | Facial pallor, yawning, neck tightness; no true pain yet |
| Aura (if present) | 5–60 minutes before headache | Visual or sensory symptoms; facial numbness rare and transient |
| Headache with facial spread | 1–72 hours | Pain extends from temple or eye into cheek, jaw, or teeth |
| Allodynia window | 1–4 hours into attack | Light touch on face becomes painful; grooming hurts |
| Postdrome | 24–48 hours after | Facial tenderness, "hangover" sensitization, low-grade ache |
| Interictal baseline | Between attacks | Face normally pain-free; persistent facial pain suggests another cause |
A key non-obvious detail: facial pain that consistently precedes the headache by more than an hour, or that persists unchanged for days after the headache resolves, is atypical for migraine. The trigeminovascular system usually normalizes within 24 to 48 hours. Persistent facial pain points toward trigeminal neuralgia, temporomandibular disorder, or a secondary cause.
Facial Migraine Versus Its Look-Alikes: The Comparison
Not all facial pain with headache is migraine. The trade-off table below separates the most common alternatives by their distinguishing features and typical first-line management.
| Condition | Pain quality and location | Key trigger or sign | Typical first step |
|---|---|---|---|
| Facial migraine | Throbbing, one-sided, eye or cheek, 4–72 hours | Nausea, light sensitivity, pulsing | Triptan or NSAID at onset |
| Trigeminal neuralgia | Sharp, electric, seconds-long shocks | Chewing, wind, touch on a trigger point | Carbamazepine; neurology referral |
| Sinusitis | Pressure, worse bending forward | Fever, purulent discharge, >10 days | Imaging if atypical; not antibiotics by default |
| Temporomandibular disorder | Aching jaw, click, limited opening | Chewing, clenching, morning soreness | Dental or oral medicine evaluation |
| Cluster headache | Severe eye pain with tearing, restlessness | 15–180 minutes, same time daily | High-flow oxygen, triptan |
| Dental source | Localized tooth pain, temperature sensitivity | Cavity, abscess, bite change | Dental exam and imaging |
The distinguishing leverage is duration and character. Migraine facial pain lasts hours and throbs. Trigeminal neuralgia lasts seconds and stabs. Cluster headache lasts under three hours and drives pacing. Getting this wrong sends patients down years of ineffective treatment.
Corrected Misconceptions and Professional Caveats
The most persistent misconception is that facial pain with migraine means the migraine has "spread" or worsened into a dangerous new phase. In most cases it means the attack is expressing itself in a branch of the same nerve, and it responds to the same acute treatments.
A second correction: facial pain is not a sign of a sinus infection just because it sits over the cheek. The sphenopalatine ganglion and V2 fibers produce identical pressure sensations. The 2017 International Classification of Headache Disorders criteria do not require imaging for typical migraine, even with facial spread, when the neurologic exam is normal.
A third, less obvious point: medication overuse can convert episodic facial pain into a daily, burning pattern. Using acute migraine drugs more than 10 to 15 days per month (depending on the drug class) can produce a refractory daily facial ache that mimics a new disease. The fix is withdrawal, not a new diagnosis.
A professional caveat worth stating plainly: facial allodynia during attacks predicts a poorer response to triptans and a higher risk of chronification. In cohort data, patients with cutaneous allodynia were roughly two to three times more likely to progress to chronic migraine (15 or more headache days per month). That makes facial pain a prognostic signal, not just a symptom.
What to Actually Do: Practical Actions
If facial pain accompanies your migraines, the goal is to confirm the pattern and treat early, not to chase each new symptom with a new specialist.
- Track the relationship between facial pain and headache in a diary for 8 to 12 weeks, noting timing, side, and whether touch hurts.
- Treat at the first sign of facial throbbing, not after the headache peaks; triptan efficacy drops once allodynia is established.
- Avoid more than 10 to 15 acute-treatment days per month to prevent medication overuse.
- Get a dental and temporomandibular joint exam if jaw pain dominates or if chewing triggers it.
- Ask about preventive therapy if facial pain occurs on more than 4 to 8 headache days per month.
- Keep a list of red flags and seek urgent care if any appear.
In plain terms: the diary does the diagnostic work, and early treatment does the therapeutic work.
Red Flags: When Facial Pain Is Not Migraine
Some facial pain patterns require same-day or urgent evaluation. These warnings are not negotiable, and they override any migraine history.
- Sudden, severe facial pain reaching maximum within 60 seconds (thunderclap), which can signal vascular events.
- Facial pain with fever, neck stiffness, rash, or confusion.
- Vision loss, double vision, or a pupil that stays dilated.
- Facial droop, weakness, numbness, or trouble speaking.
- Pain after head or facial trauma, or new pain after age 50.
- Pain with weight loss, night sweats, or a history of cancer.
Any single item on this list warrants prompt medical assessment, even in a person with a long migraine history. Roughly 1 to 3 percent of headache presentations in emergency settings turn out to be secondary causes, and facial involvement raises that index of suspicion.
Limits of the Evidence and Open Questions
The trigeminal mechanism is established, but the exact reason some migraineurs express pain in facial branches and others do not remains uncertain. Genetic variation in calcitonin gene-related peptide signaling and differences in brainstem excitability are hypotheses under active study, not settled facts.
Prevalence figures also vary widely by setting. Clinic-based samples report higher facial involvement (up to 60 percent) than population surveys (closer to 35 to 45 percent), likely because referred patients have more severe disease. Reconciling these: expect facial pain in roughly 4 in 10 migraineurs overall, and up to 6 in 10 in specialty care.
Finally, the evidence for treating facial-predominant migraine differently from standard migraine is thin. Most trials did not stratify by facial involvement, so current guidance extrapolates from general migraine data. That gap is a reason to treat the confirmed pattern rather than a label, and to reassess if the face becomes the dominant, persistent site of pain.